Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Poon · SciRah

Researcher profile · Semantic Scholar

J. Poon

Share profile

J. Poon — researcher profile on SciRah

h-index: 10
Works: 23
Citations: 405

Most-cited papers

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias
I. Gojo, M. Sadowska, Alison R. Walker, E. Feldman +10 more
2013Cancer Chemotherapy and Pharmacology85 citations Open access
Semantic Scholar
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
P. Richardson, S. Trudel, R. Popat, M. Mateos +27 more
2023New England Journal of Medicine70 citations Open access
Semantic Scholar
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
C. Niemeyer, C. Flotho, D. Lipka, J. Starý +21 more
2021Blood Advances52 citations Open access
Semantic Scholar
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies
M. Mita, A. Mita, Jennifer L Moseley, J. Poon +13 more
2017British Journal of Cancer50 citations Open access
Semantic Scholar
Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies
Da Zhang, M. Mita, G. Shapiro, J. Poon +6 more
2012Cancer Chemotherapy and Pharmacology28 citations
Semantic Scholar
Update on the Phase I Study of the Cyclin Dependent Kinase Inhibitor Dinaciclib (SCH 727965) In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Confirmation of Clinical Activity and Feasibility of Long-Term Administration
J. Flynn, Jeffrey A. Jones, L. Andritsos, K. Blum +9 more
201028 citations
Semantic Scholar
Educator Competencies for Personalized, Learner-Centered Teaching.
Rebecca E. Wolfe, J. Poon
201514 citations
Semantic Scholar
A phase I study of the CDK inhibitor dinaciclib (SCH 727965) administered every 3 weeks in patients (pts) with advanced malignancies: Final results.
M. Mita, A. Mita, Jennifer L Moseley, J. Poon +12 more
2011Journal of Clinical Oncology14 citations
Semantic Scholar
Phase II Study of the Cyclin-Dependent Kinase (CDK) Inhibitor Dinaciclib (SCH 727965) In Patients with Advanced Acute Leukemias
I. Gojo, Alison R. Walker, Maureen A. Cooper, E. Feldman +7 more
201013 citations
Semantic Scholar
Phase I study of the CDK inhibitor dinaciclib (SCH 727965) in patients (pts) with relapsed/refractory CLL.
J. Flynn, Jeffrey A. Jones, L. Andritsos, K. Blum +12 more
2011Journal of Clinical Oncology10 citations
Semantic Scholar
Early Evidence of Anti-Lymphoma Activity of the Cyclin Dependent Kinase Inhibitor Dinaciclib (SCH 727965) In Heavily Pre-Treated Low Grade Lymphoma and Diffuse Large Cell Lymphoma Patients
R. Baiocchi, J. Flynn, Jeffrey A. Jones, K. Blum +7 more
201010 citations
Semantic Scholar
Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors
J. Fangusaro, M. Cefalo, M. Garrè, L. Marshall +12 more
2021Frontiers in Oncology8 citations Open access
Semantic Scholar
A phase II clinical study of pomalidomide (CC-4047) monotherapy for children and young adults with recurrent or progressive primary brain tumors.
J. Fangusaro, F. Locatelli, M. Garrè, L. Marshall +12 more
2019Journal of Clinical Oncology7 citations
Semantic Scholar
Upfront azacitidine (AZA) in juvenile myelomonocytic leukemia (JMML): Interim analysis of the prospective AZA-JMML-001 study.
C. Niemeyer, C. Flotho, D. Lipka, J. Starý +16 more
2019Journal of Clinical Oncology7 citations
Semantic Scholar
Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
Maureen M. O'Brien, Todd A. Alonzo, Todd M. Cooper, John E. Levine +11 more
2021Pediatric Blood & Cancer5 citations Open access
Semantic Scholar
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial
F. Locatelli, Karin Belander Strålin, Irene Schmid, J. Sevilla +9 more
2024Pediatric Blood & Cancer3 citations Open access
Semantic Scholar
Repurposing the HMG-CoA Reductase Inhibitor Atorvastatin for SRD5A3-CDG
Hiba Daghar, Seul Kee Byeon, C. Maios, J. Poon +8 more
2026bioRxiv1 citations Open access
Semantic Scholar
Antipsychotic Drug Prescriptions for Transition-Age Youth on the Autism Spectrum.
T. Benevides, Jessica E. Rast, Brian Lee, Kristy A. Anderson +5 more
2026Journal of Autism and Developmental Disorders1 citations Open access
Semantic Scholar
Correction: Antipsychotic Drug Prescriptions for Transition-Age Youth on the Autism Spectrum
T. Benevides, Jessica E. Rast, Brian Lee, Kristy A. Anderson +5 more
2026Journal of Autism and Developmental Disorders0 citations Open access
Semantic Scholar
Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation
Hiba Daghar, Seul Kee Byeon, C. Maios, J. Poon +8 more
2026Communications Medicine0 citations Open access
Semantic Scholar
EXECUTIVE SUMMARY Better Together: How inclusive design as a policy process impacts stakeholder understanding, ownership, and engagement in assessment and accountability innovation - Allen County, Kentucky Case Study
J. Poon, D. DiGiacomo, R. Harvey, Lauren Ho +1 more
20250 citations Open access
Semantic Scholar
PS1455 RESPONSE TO UP-FRONT AZACITIDINE IN JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML): INTERIM ANALYSIS OF THE PROSPECTIVE EUROPEAN MULTICENTER STUDY AZA-JMML-001
C. Niemeyer, C. Flotho, D. Lipka, J. Starý +17 more
2019HemaSphere0 citations Open access
Semantic Scholar
Title: A Randomized, Controlled Trial of Integrated vs. Standard Palliative Care in Patients with Advanced NSCLC
J. Temel, Panos Fidias, L. Sequist, R. Heist +20 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Karen A. Small×8
Invite
Karen A. Small — researcher profile on SciRah
R. Bannerji×8
Invite
R. Bannerji — researcher profile on SciRah
Da Zhang×6
Invite
Da Zhang — researcher profile on SciRah
B. Benettaib×6
Invite
B. Benettaib — researcher profile on SciRah

×6

Invite

M. Simcock — researcher profile on SciRah

P. Statkevich×6

Invite

P. Statkevich — researcher profile on SciRah

Invite

N. Biserna — researcher profile on SciRah

M. M. van den Heuvel-Eibrink×4

Invite

M. M. van den Heuvel-Eibrink — researcher profile on SciRah

F. Locatelli×4

Invite

F. Locatelli — researcher profile on SciRah

Invite

Ya-Li Zhu — researcher profile on SciRah

Invite

C. Flotho — researcher profile on SciRah

Invite

D. Lipka — researcher profile on SciRah